IK-1001

Sodium sulfide for injection · Mallinckrodt

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for IK-1001, covering 2017-05-19 to 2017-05-19. Get the full timeline:

Most recent: Clinical Trial Update: IK-1001 (Sodium Sulfide (Na2S) for Injection) in Subjects With Acute ST-Segment Elevation Myocardial Infarction [Phase 2]

See pricing